Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Claas

Showing results (161-170 of 262) with videos related to

Pageof 27
Sort By:
Human Immunology|October 1, 1992
Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51G J Bouma, P M van der Meer-Prins, F P van Bree, et al.
The Journal of Investigative Dermatology|December 24, 1997
Differential effects of sunscreens on UVB-induced immunomodulation in humansH M Hurks, R G van der Molen, C Out-Luiting, et al.
The Journal of Investigative Dermatology|September 1, 1990
Analysis of the protective effect of topical sunscreens on the UVB-radiation-induced suppression of the mixed-lymphocyte reactionA M Mommaas, M C van Praag, J N Bouwes Bavinck, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantationN E van Emmerik, E H Loonen, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathwaysN M van Besouw, L M Vaessen, C J Knoop, et al.
Lancet (London, England)|March 26, 1994
Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanismB J van der Mast, N Hornstra, M B Ruigrok, et al.
Transplantation|February 1, 1993
Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-BW22 splitC C Baan, L M Vaessen, F ten Kate, et al.
Transplantation|July 29, 1998
C1.7 monoclonal antibody designates high-avidity CD4+ cytotoxic T lymphocytes involved in clinical heart rejectionN E van Emmerik, C J Knoop, L M Vaessen, et al.
Transplantation|June 8, 2001
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitroR Wassmuth, I A Hauser, K Schuler, et al.
Transplantation|April 15, 1995
The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal graftsD L Roelen, E van Beelen, S P van Bree, et al.
Pageof 27

Showing results (161-170 of 262) with videos related to

Sort By:
Pageof 27
Human Immunology|October 1, 1992
Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51G J Bouma, P M van der Meer-Prins, F P van Bree, et al.
The Journal of Investigative Dermatology|December 24, 1997
Differential effects of sunscreens on UVB-induced immunomodulation in humansH M Hurks, R G van der Molen, C Out-Luiting, et al.
The Journal of Investigative Dermatology|September 1, 1990
Analysis of the protective effect of topical sunscreens on the UVB-radiation-induced suppression of the mixed-lymphocyte reactionA M Mommaas, M C van Praag, J N Bouwes Bavinck, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantationN E van Emmerik, E H Loonen, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathwaysN M van Besouw, L M Vaessen, C J Knoop, et al.
Lancet (London, England)|March 26, 1994
Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanismB J van der Mast, N Hornstra, M B Ruigrok, et al.
Transplantation|February 1, 1993
Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-BW22 splitC C Baan, L M Vaessen, F ten Kate, et al.
Transplantation|July 29, 1998
C1.7 monoclonal antibody designates high-avidity CD4+ cytotoxic T lymphocytes involved in clinical heart rejectionN E van Emmerik, C J Knoop, L M Vaessen, et al.
Transplantation|June 8, 2001
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitroR Wassmuth, I A Hauser, K Schuler, et al.
Transplantation|April 15, 1995
The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal graftsD L Roelen, E van Beelen, S P van Bree, et al.
Pageof 27